Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration
Yucheng Fu(Ruijin Hospital), Weibin Zhang(Ruijin Hospital)
Cited by 14
Related Papers
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
|Biomarker Research|2022|57
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
|Frontiers in Oncology|2023|15